RPS15 and esophageal squamous cell carcinoma: Combining functional experiments in vitro and in vivo and targeted drug virtual screening, folic acid was found to target RPS15 degradation and have a therapeutic effect on ESCC, and the therapeutic effect was augmented by the combination with DDP.